Jiatong Zhou
Qingchun Road 79
Hangzhou, 310003, China
Hangzhou, 310003, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
CircBARD1 suppresses tumor progression driven by H3K18 lactylation-CCNA2 axis in human bladder cancer.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: August 10, 2025
Histone deacetylase HDAC7 restricts CD8 + T cell tumor infiltration and limits immunotherapy sensitivity in bladder cancer: reversal by pinocembrin.
Journal: Journal of experimental & clinical cancer research : CR
Published: July 30, 2025
Multiple primary cancers with prostate malignant tumor as the initial diagnosis: a case report.
Journal: Discover oncology
Published: May 01, 2025
Tumor suppressing function of SLC16A7 in bladder cancer and its pan-cancer analysis.
Journal: BMC cancer
Published: December 09, 2024
Nephron sparing surgery for a patient with a complicated solitary functioning kidney and a giant pT3 renal cell carcinoma: A case report.
Journal: Frontiers in surgery
Published: November 10, 2022
Serum multi-cytokines screening identifies TRAIL and IL-10 as probable new biomarkers for prostate health index diagnostic utility adjustment in grey zone aggressive prostate cancer detection: A single-center data in China.
Journal: Frontiers in immunology
Published: March 21, 2022
Does the Gleason Score 7 Upgrading Always Predict Worse Prognosis?
Journal: Clinical genitourinary cancer
Published: February 08, 2022
Local treatment Associated With Prognosis among Men With Metastatic Prostate Cancer: A SEER-Based Study.
Journal: Clinical genitourinary cancer
Published: February 07, 2022
The modified prostate health index (PHI) outperforms PHI density in the detection of clinical prostate cancer within the PSA grey zone.
Journal: International urology and nephrology
Published: December 19, 2021
Last Updated: 09/26/2026